Healthcare >> Analyst Interviews >> April 8, 2013

Opportunities in Hepatitis C and Genomic Technologies

Ferreiro, David
David Ferreiro is Executive Director and Senior Analyst at Oppenheimer & Co. Inc., covering biotechnology, life science tools and diagnostics, and in 2012 was voted best up-and-coming Life Science Tools & Diagnostics Analyst fromInstitutional Investor’s All-America’s Research Team. Prior to Oppenheimer & Co. Inc., Dr. Ferreiro worked at JMP Securities on the medical devices research team. He began his Wall Street career at Banc of America Securities LLC covering biotechnology. Previously, he was a Graduate Research Scientist at Albert Einstein College of Medicine. Dr. Ferreiro holds a B.A. in biology from Middlebury College, and an M.S. and a Ph.D. in microbiology and immunology from the Albert Einstein College of Medicine. Profile
TWST: Can you begin with an overview of your coverage, including some of the specific names you follow?

Dr. Ferreiro: My coverage is kind of eclectic. I cover large-cap biotech and some